Lexicon Pharmaceuticals
LXRX
#6255
Rank
ยฃ0.76 B
Marketcap
ยฃ1.71
Share price
-1.28%
Change (1 day)
112.81%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -ยฃ0.05217

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ0.05192. In 2025 the company made an earnings per share (EPS) of -ยฃ0.10 an increase over its 2024 EPS that were of -ยฃ0.47.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.05217-49.76%
2025-ยฃ0.10-78.13%
2024-ยฃ0.47-20%
2023-ยฃ0.5931.15%
2022-ยฃ0.45-0%
2021-ยฃ0.4510.91%
2020-ยฃ0.41-145.08%
2019ยฃ0.90-206.09%
2018-ยฃ0.85-5.74%
2017-ยฃ0.90-10.95%
2016-ยฃ1.022640%
2015-ยฃ0.03709-96.34%
2014-ยฃ1.01-2.53%
2013-ยฃ1.04-9.09%
2012-ยฃ1.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ13.51-26,128.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ4.10-8,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ31.55-60,857.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ4.53 8,628.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ5.82-11,300.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ0.01483-71.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ0.56 971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.04-2,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ1,214 2,338,114.29%๐Ÿ‡บ๐Ÿ‡ธ USA